| | |
Per Share
|
| |
Per Pre-Funded
Warrant |
| |
Total
|
| |||||||||
Public offering price
|
| | | $ | 4.750 | | | | | $ | 4.749 | | | | | $ | 59,997,899.70 | | |
保証割引と手数料(1)
|
| | | $ | 0.285 | | | | | $ | 0.285 | | | | | $ | 3,600,000.30 | | |
費用が差し引かれていないMarinus PharmPharmticals,Inc.収益
|
| | | $ | 4.465 | | | | | $ | 4.464 | | | | | $ | 56,397,899.40 | | |
|
本募集説明書の副刊
について
|
| | | | S-i | | |
|
募集説明書補足要約
|
| | | | S-1 | | |
|
THE OFFERING
|
| | | | S-2 | | |
|
RISK FACTORS
|
| | | | S-4 | | |
|
前向き陳述に関する説明
|
| | | | S-7 | | |
|
USE OF PROCEEDS
|
| | | | S-10 | | |
|
DILUTION
|
| | | | S-11 | | |
|
事前出資株式証説明
|
| | | | S-13 | | |
|
重要なアメリカ連邦所得税結果
|
| | | | S-15 | | |
|
UNDERWRITING
|
| | | | S-21 | | |
|
LEGAL MATTERS
|
| | | | S-26 | | |
|
EXPERTS
|
| | | | S-26 | | |
|
どこでもっと情報を見つけることができますか
|
| | | | S-26 | | |
|
参照によっていくつかの情報
を組み込む
|
| | | | S-26 | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
前向きメッセージ警告声明
|
| | | | 2 | | |
|
OUR COMPANY
|
| | | | 4 | | |
|
RISK FACTORS
|
| | | | 5 | | |
|
USE OF PROCEEDS
|
| | | | 6 | | |
|
私たちの証券概要
|
| | | | 7 | | |
|
我々の普通株式説明
|
| | | | 8 | | |
|
我々の優先株説明
|
| | | | 11 | | |
|
債務証券説明
|
| | | | 14 | | |
|
株式証明書説明
|
| | | | 20 | | |
|
DESCRIPTION OF UNITS
|
| | | | 22 | | |
|
証券の合法的所有権
|
| | | | 23 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 26 | | |
|
LEGAL MATTERS
|
| | | | 29 | | |
|
EXPERTS
|
| | | | 29 | | |
|
引用統合
|
| | | | 30 | | |
|
どこでもっと情報を見つけることができますか
|
| | | | 30 | | |
|
今回発行された1株当たり発行価格
|
| | | | | | | | | $ | 4.75 | | |
|
2022年9月30日までの1株当たり有形帳簿純価値
|
| | | | 2.20 | | | | | | | | |
|
本年度は、購入者の1株当たりの有形帳簿純価値の増加によるものである
offering |
| | | | 0.57 | | | | | | | | |
|
今回の発行直後の調整後の1株当たりの有形帳簿純価値
|
| | | | | | | | | | 2.77 | | |
|
今回発売中の購入者の1株当たりの割引
|
| | | | | | | | | $ | 1.98 | | |
Underwriter
|
| |
Number of
Shares |
| |
Number of
Pre-Funded Warrants |
| ||||||
SVB Securities LLC
|
| | | | 4,973,684 | | | | | | 994,737 | | |
RBC資本市場有限責任会社
|
| | | | 4,289,474 | | | | | | 857,895 | | |
カントー·フィッツジェラルド社は
|
| | | | 1,263,158 | | | | | | 252,632 | | |
Total
|
| | | | 10,526,316 | | | | | | 2,105,264 | | |
| | | | | | | | | | | | | | |
Total
|
| |||||||||
| | |
Per
Share |
| |
Per
Pre-Funded Warrant |
| |
Without
Option |
| |
With
Option |
| ||||||||||||
初公募株価格
|
| | | $ | 4.750 | | | | | $ | 4.749 | | | | | $ | 59,997,899.74 | | | | | $ | 68,997,900.49 | | |
保証割引と手数料
|
| | | $ | 0.285 | | | | | $ | 0.285 | | | | | $ | 3,600,000.30 | | | | | $ | 4,140,000.35 | | |
費用が差し引かれていない収益は私たちに
|
| | | $ | 4.465 | | | | | $ | 4.464 | | | | | $ | 56,397,899.44 | | | | | $ | 64,857,900.14 | | |
Item
|
| |
Page
Number |
| |||
About This Prospectus
|
| | |
|
1
|
| |
前向きメッセージ警告声明
|
| | |
|
2
|
| |
Our Company
|
| | |
|
4
|
| |
Risk Factors
|
| | |
|
5
|
| |
Use of Proceeds
|
| | |
|
6
|
| |
私たちの証券概要
|
| | |
|
7
|
| |
我々の普通株式説明
|
| | |
|
8
|
| |
我々の優先株説明
|
| | |
|
11
|
| |
債務証券説明
|
| | |
|
14
|
| |
株式証明書説明
|
| | |
|
20
|
| |
Description of Units
|
| | |
|
22
|
| |
証券の合法的所有権
|
| | |
|
23
|
| |
Plan of Distribution
|
| | |
|
26
|
| |
LEGAL MATTERS
|
| | |
|
29
|
| |
Experts
|
| | |
|
29
|
| |
引用統合
|
| | |
|
30
|
| |
どこでもっと情報を見つけることができますか
|
| | |
|
30
|
| |